✦ LIBER ✦

Essential considerations for evaluating therapeutic effectiveness in Fabry disease

✍ Scribed by Desnick, Robert J.; Doheny, Dana O.; Weidemann, Frank; Politei, Juan M.; Germain, Dominique P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Considerations in the Design of Preclini

✍ J. A. CAVAGNARO; S. LIU 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

EVALUATING NUTRACEUTICAL PRODUCTS FOR TH

✍ Chou, Emily C.; Lange, Dirk; Adomat, Hans; Guns, Emma; Chew, Ben H 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB

CD77 as a biomarker for effectiveness of

✍ Semiramis Hadad; Ester Miranda Pereira; Adalberto Socorro da Silva; Anaregina de 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

CD77 as a Biomarker for Effectiveness of

✍ Ester Miranda Pereira; Adalberto Socorro da Silva; Semiramis Jamil Hadad do Mont 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Biological markers for evaluating therap

✍ Pinazo, Maria-Jesús ;Thomas, M Carmen ;Bua, Jacqueline ;Perrone, Alina ;Schijman 📂 Article 📅 2014 🏛 Expert Reviews 🌐 English ⚖ 422 KB

P23—New Guidelines for the Evaluation an

✍ A. Tylki-Szymanska; R.J. Hopkin; M. Banikazemi; D.P. Germain; M. Mauer; D.G. War 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB